By Kyle Longwell, Product Manager of Software and Clinical Care at Cochlear Americas.
Cochlear’s recent FDA approval of Remote Check for cochlear implant recipients drastically changes the virtual care landscape for hearing health professionals.
The FDA’s expedited approval of Cochlear’s Remote Check offering during the COVID-19 crisis underscores that at-home hearing healthcare support needs to be prioritized, accessible and convenient for patients now more than ever. Professionals now have the ability to offer an at-home, clinician-enabled testing tool that allows recipients with a Cochlear™ Nucleus® 7 or Kanso® 2 Sound Processor to complete a series of hearing tests from their compatible iOS device using the Nucleus Smart App.*
Results are then sent remotely to the recipient’s clinic for review by their clinician. The clinician can review the results by logging into the myCochlear Clinic professional portal, where they can access a comprehensive overview of the patient’s hearing health. This snapshot of a patient’s hearing health can help the clinician quickly determine whether a patient is on track, or whether further clinical intervention is required.**
For cochlear implant recipients, Remote Check is designed to reduce unnecessary travel burdens to the clinic, to provide immediate hearing/patient data to the clinician for troubleshooting requests and to provide a convenient, time-saving option of care.
Using this technology, clinicians will not only be able to provide a more convenient avenue of care, but they can also free up more appointment times to manage the anticipated growth in the hearing implant market and/or the wave of patients coming in to seek hearing implant treatment after the COVID pandemic. A solution like Remote Check can help clinicians prioritize case loads, reduce unnecessary visits for patients progressing well, spend quality time with patients who have complex needs and help more patients seeking initial cochlear implant candidacy assessment.
Over the last decade, Cochlear has been heavily focused on expanding and improving digital and remote care services. During these unprecedented times, we’re proud Cochlear is the leader in providing innovative solutions that allow our clinic partners to continue treating their patients without the need for an in-person appointment, ultimately ensuring our recipients continue to hear and stay connected.
Read more about Remote Check on Cochlear ProNews or watch this webinar.
* To use Remote Check, a patient requires: latest version of the Nucleus Smart App (Remote Check is part of this App) running on a compatible Apple device (iPhone or iPod Touch); Nucleus 7 Sound Processors with implant models: CI24RE, CI512, CI513, CI522, CI532, CI612, CI622 and CI632; compatible firmware on the Nucleus 7 Sound Processor (126.96.36.199 or later). A clinician requires access to Cochlear’s secure web-based myCochlear.com Professional Portal to access and review patient results. The recommended browser for accessing the Professional Portal is Google Chrome. A clinician also requires Custom Sound 5.1 or later software to upgrade the patient’s firmware to enable access to Remote Check. For sound processor and app compatibility information, visit https://www.cochlear.com/compatibility.
** Remote Check does not replace clinical care and does not involve remote programming of the sound processor.
Apple, iPhone and iPod touch are trademarks of Apple Inc., registered in the U.S. and other countries.
Remote Check is intended for ages 6 and older. The Remote Check feature is only visible and accessible if the feature is enabled by a clinician. Clinicians should consider the suitability of the feature before enabling Remote Check.